Tech Company Financing Transactions

Gentris Funding Round

On 4/28/2005, Gentris received $5 million in Series C funding from Mitsui & Co. Venture Partners.

Transaction Overview

Company Name
Announced On
4/28/2005
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series C
Proceeds Purpose
The funding will allow Gentris to proceed with its plan to develop and distribute pharmacogenomic diagnostic testing kits.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
133 Southcenter Court 400
Morrisville, NC 27560
USA
Email Address
Overview
Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions.
Profile
Gentris LinkedIn Company Profile
Social Media
Gentris Company Twitter Account
Company News
Gentris News
Facebook
Gentris on Facebook
YouTube
Gentris on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Amelia Warner
  Amelia Warner LinkedIn Profile  Amelia Warner Twitter Account  Amelia Warner News  Amelia Warner on Facebook
Chief Financial Officer
Pamela Prior
  Pamela Prior LinkedIn Profile  Pamela Prior Twitter Account  Pamela Prior News  Pamela Prior on Facebook
Chief Scientific Officer
Scott Clark
  Scott Clark LinkedIn Profile  Scott Clark Twitter Account  Scott Clark News  Scott Clark on Facebook
VP - Engineering
John Doyle
  John Doyle LinkedIn Profile  John Doyle Twitter Account  John Doyle News  John Doyle on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/28/2005: Receptor BioLogix venture capital transaction
Next: 5/2/2005: Traffic.com venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary